$20.6 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$168.76 - $264.75The lowest and highst price in the last 52 weeks.
56.64xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$0.00 (0.0%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
|Market Cap||$20.6 Billion|
|Enterprise Value||$19.9 Billion|
|Dividend Yield||$0.00 (0.0%)|
|1 Year Return||+43.5%|
|Outstanding Shares||79.6 Million|
|Avg 30 Day Volume||406 Thousand|
|Earnings per Share||$6.84|
|Price to Sales Ratio||7.52|
|Price to Book Ratio||10.83|
|Revenue to Enterprise Value||6.77|
|EBIT to Enterprise Value||47.54|
|Total Debt to Enterprise Value||0.02|
|Debt to Equity||0.17|
|Gross Profit||$840 Million|
|Net Income||$338 Million|
|Quarterly Earnings Growth (YoY)||+11.4%|
|Return on Equity||16.66%|
|Return on Assets||9.42%|
|Return on Invested Capital||16.89%|
No summary available.Seeking Alpha, 23 days ago
New York, United States :Our research wizards at Decisive Markets Insights have effectively crafted a report on the Oncology Clinical Trial MARKET market that explicates the essential areas of mark...OpenPR, 29 days ago
Latest added Global Clinical Trial Imaging Market research study by DBMR offers detailed product outlook and elaborates market review till 2020. This report provides analysis of the Global Clinical...OpenPR, 30 days ago